BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17189693)

  • 1. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain.
    Sexton KB; Witte MD; Blum G; Bogyo M
    Bioorg Med Chem Lett; 2007 Feb; 17(3):649-53. PubMed ID: 17189693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian legumain - A lysosomal cysteine protease with extracellular functions?
    Lunde NN; Bosnjak T; Solberg R; Johansen HT
    Biochimie; 2019 Nov; 166():77-83. PubMed ID: 31181234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.
    Lee J; Bogyo M
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1340-3. PubMed ID: 22243962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity of schistosome versus human legumain determined by P1-P3 peptide libraries.
    Mathieu MA; Bogyo M; Caffrey CR; Choe Y; Lee J; Chapman H; Sajid M; Craik CS; McKerrow JH
    Mol Biochem Parasitol; 2002 Apr; 121(1):99-105. PubMed ID: 11985866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protease-responsive fluorescent probe for sensitive imaging of legumain activity in living tumor cells.
    Li X; Liu Q; Ye S; Wang S; Li K; Lv G; Peng Y; Qiu L; Lin J
    Chem Biol Drug Des; 2019 Aug; 94(2):1494-1503. PubMed ID: 31002467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
    Manoury B; Hewitt EW; Morrice N; Dando PM; Barrett AJ; Watts C
    Nature; 1998 Dec; 396(6712):695-9. PubMed ID: 9872320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of near-infrared fluorophore (NIRF)-labeled activity-based probes for in vivo imaging of legumain.
    Lee J; Bogyo M
    ACS Chem Biol; 2010 Feb; 5(2):233-43. PubMed ID: 20017516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of legumain.
    Schwarz G; Brandenburg J; Reich M; Burster T; Driessen C; Kalbacher H
    Biol Chem; 2002 Nov; 383(11):1813-6. PubMed ID: 12530547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole inhibits the cysteine protease legumain by binding to the active site.
    Bosnjak T; Solberg R; Hemati PD; Jafari A; Kassem M; Johansen HT
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):89-99. PubMed ID: 30916878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mammalian Cysteine Protease Legumain in Health and Disease.
    Solberg R; Lunde NN; Forbord KM; Okla M; Kassem M; Jafari A
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs.
    Bogyo M; Verhelst S; Bellingard-Dubouchaud V; Toba S; Greenbaum D
    Chem Biol; 2000 Jan; 7(1):27-38. PubMed ID: 10662686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of legumain in health and disease.
    Dall E; Brandstetter H
    Biochimie; 2016 Mar; 122():126-50. PubMed ID: 26403494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes.
    Poreba M; Solberg R; Rut W; Lunde NN; Kasperkiewicz P; Snipas SJ; Mihelic M; Turk D; Turk B; Salvesen GS; Drag M
    Cell Chem Biol; 2016 Aug; 23(8):1023-35. PubMed ID: 27478158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the development of legumain-selective chemical probes and peptide prodrugs.
    Poreba M
    Biol Chem; 2019 Nov; 400(12):1529-1550. PubMed ID: 31021817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of radioactive/fluorescent peptide probes for imaging of legumain activity.
    Fuchigami T; Itagaki K; Ishikawa N; Yoshida S; Nakayama M
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126629. PubMed ID: 31445852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IrAE: an asparaginyl endopeptidase (legumain) in the gut of the hard tick Ixodes ricinus.
    Sojka D; Hajdusek O; Dvorák J; Sajid M; Franta Z; Schneider EL; Craik CS; Vancová M; Buresová V; Bogyo M; Sexton KB; McKerrow JH; Caffrey CR; Kopácek P
    Int J Parasitol; 2007 Jun; 37(7):713-24. PubMed ID: 17336985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity.
    Poreba M; Salvesen GS; Drag M
    Nat Protoc; 2017 Oct; 12(10):2189-2214. PubMed ID: 28933778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pig kidney legumain: an asparaginyl endopeptidase with restricted specificity.
    Dando PM; Fortunato M; Smith L; Knight CG; McKendrick JE; Barrett AJ
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):743-9. PubMed ID: 10215615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase.
    Loak K; Li DN; Manoury B; Billson J; Morton F; Hewitt E; Watts C
    Biol Chem; 2003 Aug; 384(8):1239-46. PubMed ID: 12974392
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.